中文版
Inhibitory Antibodies
Ranibizumab
Catalog No. :
CLA1031
Product Name :
Ranibizumab
CAS No. :
347396-82-1
Synonyms :
RG-6321 (anti-VEGF)
Chemical Name :
Molecular Formula :
Molecular Weight :
Molecular Structure :
Appearance :
Specification :
95+%
Application :
VEGFR
Registration :
Storage Condition :
Sealed and stored at -70±15℃ for long term storage & 2-8℃ for short term storage (<6 months)

Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.

  • Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.

  • No Photo

    Etanercept

    Anakinra (IL-1Ra)

    Bevacizumab biosimilar

Request A Quote
Your Name(required)
Email(required)
Product Name(required)
Country or Region(required)
Organization Name(required)
Messages(required)
Captcha(required)
Sending...